DCM
GBT

Driehaus Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Driehaus Capital Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-805,861
Closed -$25.7M – 430
2022
Q2 		$25.7M Buy
+805,861
New +$23.6M 0.42% 71
2020
Q4 		– Sell
-3,902
Closed -$215K – 487
2020
Q3 		$215K Sell
3,902
-235,196
-98% -$14.9M ﹤0.01% 379
2020
Q2 		$15.1M Sell
239,098
-134,786
-36% -$9.24M 0.37% 84
2020
Q1 		$19.1M Buy
373,884
+16,974
+5% +$1.14M 0.64% 40
2019
Q4 		$28.4M Buy
356,910
+186,451
+109% +$11M 0.75% 27
2019
Q3 		$8.27M Sell
170,459
-39,338
-19% -$2.05M 0.27% 102
2019
Q2 		$11M Buy
209,797
+59,655
+40% +$3.43M 0.35% 78
2019
Q1 		$7.95M Sell
150,142
-4,380
-3% -$215K 0.3% 96
2018
Q4 		$6.34M Sell
154,522
-40,694
-21% -$1.52M 0.27% 107
2018
Q3 		$7.42M Sell
195,216
-107,313
-35% -$4.75M 0.23% 137
2018
Q2 		$13.7M Buy
302,529
+15,658
+5% +$713K 0.46% 54
2018
Q1 		$13.9M Buy
286,871
+38,242
+15% +$2.13M 0.49% 43
2017
Q4 		$9.78M Buy
248,629
+84,275
+51% +$3.15M 0.37% 65
2017
Q3 		$5.1M Buy
164,354
+6,893
+4% +$194K 0.2% 140
2017
Q2 		$4.31M Buy
157,461
+11,879
+8% +$353K 0.16% 152
2017
Q1 		$5.37M Buy
+145,582
New +$3.67M 0.18% 126
2016
Q4 		– Sell
-374,108
Closed -$8.62M – 679
2016
Q3 		$8.62M Buy
374,108
+229,196
+158% +$4.37M 0.29% 69
2016
Q2 		$2.4M Sell
144,912
-882
-0.6% -$17.8K 0.09% 240
2016
Q1 		$2.31M Sell
145,794
-55,468
-28% -$986K 0.07% 263
2015
Q4 		$6.51M Sell
201,262
-42,137
-17% -$1.82M 0.22% 107
2015
Q3 		$10.3M Buy
+243,399
New +$11.5M 0.37% 65

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Driehaus Capital Management's GBT Position: Q3 2022 in Review

Driehaus Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 805,861 shares — an estimated $25.7M sold.

Driehaus Capital Management first reported a position in GBT in Q3 2015 and held it in 21 quarters. The position peaked at $28.4M in Q4 2019. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Driehaus Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Driehaus Capital Management sold 805,861 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $25.7M.
  • Driehaus Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 21 quarters.
  • Driehaus Capital Management's Global Blood Therapeutics, Inc. position peaked at $28.4M in Q4 2019.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Driehaus Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.